Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data

(2014) Stella G Muthuri et al.   Lancet Respiratory Medicine

Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection

(2013) Hai-Nv Gao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pandemic Influenza Viruses — Hoping for the Road Not Taken

(2013) David M. Morens et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China

(2013) Qun Li et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emergency Use Authorization for Intravenous Peramivir: Evaluation of Safety in the Treatment of Hospitalized Patients Infected With 2009 H1N1 Influenza A Virus

(2012) A. Sorbello et al.   CLINICAL INFECTIOUS DISEASES

Efficacy, Safety, and Pharmacokinetics of Intravenous Peramivir in Children with 2009 Pandemic H1N1 Influenza A Virus Infection

(2011) Norio Sugaya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Intravenous Peramivir for Treatment of Influenza A and B Virus Infection in High-Risk Patients

(2011) Shigeru Kohno et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phase III Randomized, Double-Blind Study Comparing Single-Dose Intravenous Peramivir with Oral Oseltamivir in Patients with Seasonal Influenza Virus Infection

(2011) Shigeru Kohno et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States

(2011) Jaime E. Hernandez et al.   CLINICAL INFECTIOUS DISEASES

Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment

(2011) Jaime E. Hernandez et al.   Influenza and Other Respiratory Viruses

Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life

(2011) A. Kumar   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus Infection

(2010) S. Kohno et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro

(2010) Larisa V Gubareva et al.   ANTIVIRAL THERAPY

Estimating the Burden of 2009 Pandemic Influenza A (H1N1) in the United States (April 2009-April 2010)

(2010) S. S. Shrestha et al.   CLINICAL INFECTIOUS DISEASES

Drugs in Development for Influenza

(2010) David A. Boltz et al.   DRUGS

End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life‐Threatening Disease

(2010) Michael G. Ison et al.   JOURNAL OF INFECTIOUS DISEASES

Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Peramivir Pharmacokinetics in Two Critically Ill Adults with 2009 H1N1 Influenza A Concurrently Receiving Continuous Renal Replacement Therapy

(2010) Jose A Bazan et al.   PHARMACOTHERAPY

Estimates of US influenza-associated deaths made using four different methods

(2009) William W. Thompson et al.   Influenza and Other Respiratory Viruses

The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza

(2009) Debra Birnkrant et al.   NEW ENGLAND JOURNAL OF MEDICINE